Mostacci Barbara, Licchetta Laura, Cacciavillani Carlotta, Di Vito Lidia, Ferri Lorenzo, Menghi Veronica, Stipa Carlotta, Avoni Patrizia, Provini Federica, Muccioli Lorenzo, Vignatelli Luca, Mazzoni Stefania, Tinuper Paolo, Bisulli Francesca
IRCCS Istituto delle Scienze Neurologiche di Bologna, Full Member of the ERN EpiCare, Bologna, Italy.
Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Front Neurol. 2020 Dec 18;11:613719. doi: 10.3389/fneur.2020.613719. eCollection 2020.
We explored the impact of the coronavirus disease-19 (COVID-19) emergency on the health of people with epilepsy (PwE). We also investigated their attitude toward telemedicine. The PubMed database up to September 10, 2020 was searched for questionnaire-based studies conducted in PwE during the COVID-19 emergency, and the literature retrieved was reviewed. In addition, all patients who had a telephone consultation with our center between May 7 and July 31, 2020 were invited to fill in a 57-item online questionnaire focusing on epilepsy and comorbidities, any changes in lifestyle or clinical conditions and any emergency-related problems arising during the COVID-19 emergency, and their views on telemedicine. Associations between variables were detected through test and Fisher's exact test. Univariate and multivariate logistic regression models were used to evaluate the effects of different factors on clinical conditions. Twelve studies met the literature search criteria. They showed that the rate of seizure worsening during the emergency ranged from 4 to 35% and was mainly correlated with epilepsy severity, sleep disturbances and COVID-19-related issues. Our questionnaire was filled in by 222 PwE or caregivers. One hundred (76.6%) reported unchanged clinical conditions, 25 (11.3%) an improvement, and 27 (12%) a deterioration. Reported clinical worsening was associated with a psychiatric condition and/or medication (OR = 12.59, < 0.001), sleep disorders (OR = 8.41, = 0.001), limited access to healthcare (OR = 4.71, = 0.016), and experiencing seizures during the emergency (OR = 4.51, = 0.007). Telemedicine was considered acceptable by 116 subjects (52.3%). Most PwE did not experience a significant change in their clinical conditions during the COVID-19 emergency. However, severity of epilepsy, concomitant disability, comorbid psychiatric conditions, sleep disorders and limited access to healthcare may affect their health.
我们探讨了2019冠状病毒病(COVID-19)疫情对癫痫患者健康的影响。我们还调查了他们对远程医疗的态度。检索了截至2020年9月10日的PubMed数据库中在COVID-19疫情期间针对癫痫患者开展的基于问卷的研究,并对检索到的文献进行了综述。此外,邀请了2020年5月7日至7月31日期间与我们中心进行电话咨询的所有患者填写一份包含57个条目的在线问卷,内容聚焦于癫痫及合并症、生活方式或临床状况的任何变化以及COVID-19疫情期间出现的任何与疫情相关的问题,以及他们对远程医疗的看法。通过卡方检验和Fisher精确检验检测变量之间的关联。使用单因素和多因素逻辑回归模型评估不同因素对临床状况的影响。12项研究符合文献检索标准。这些研究表明,疫情期间癫痫发作恶化率在4%至35%之间,主要与癫痫严重程度、睡眠障碍和COVID-19相关问题有关。我们的问卷由222名癫痫患者或照料者填写。100人(76.6%)报告临床状况未变,25人(11.3%)报告有所改善,27人(12%)报告恶化。报告的临床恶化与精神疾病和/或药物治疗(比值比=12.59,P<0.001)、睡眠障碍(比值比=8.41,P=0.001)、获得医疗服务受限(比值比=4.71,P=0.016)以及疫情期间癫痫发作(比值比=4.51,P=0.007)有关。116名受试者(52.3%)认为远程医疗是可以接受的。大多数癫痫患者在COVID-19疫情期间临床状况没有显著变化。然而,癫痫严重程度、伴随的残疾、合并的精神疾病、睡眠障碍以及获得医疗服务受限可能会影响他们的健康。